BioLabs Heidelberg

Three years ago, BioLabs Heidelberg embarked on an exciting journey and laid the foundation for its first European site in Germany. On August 16, 2021, we laid the cornerstone, and exactly two years later, we opened a new chapter by moving to our "home" 🏢 at Nikola-Tesla-Str. 1 in Heidelberg. As we celebrate these milestones, we're deeply grateful for the tremendous support that has fueled our growth. Marking our first year in the new location, we asked our team to reflect on our most significant achievements and their impact on the startup community: "We've transformed our new, first-in-Germany location into a vibrant, fully operational BioLabs site for our resident community. Working alongside our valuable partners, we continuously strive to meet our residents' needs and are privileged to witness their growth and our expanding community. Your steadfast support during our transition and over the past 3 years, especially the last 12 months, has been crucial in building a strong foundation. Together, we've created a thriving hub for innovation. Last year's move wasn't just a change of address—it was about enhancing our capabilities, deepening collaborations, and fostering an environment where groundbreaking ideas flourish. 🤝 🙏 Looking ahead, we're excited about the future possibilities. We're committed to continuing our mission to empower our residents, enabling them to benefit from the most recent developments in life-science technology." The BioLabs Heidelberg Team Ann-Kristin Mueller, Ornella Kossi, Stefanie Schimmel, Heiner Sähr, Johannes Fruehauf thanks: BioRN Life Science Cluster Rhine-Neckar, Beckman Coulter Life Sciences, Novo Nordisk, Thermo Fisher Scientific, AbbVie, BD, Boehringer Ingelheim, Eppendorf , Evotec, Eli Lilly and Company, Merck Gruppe, Miltenyi Biotec, QIAGEN, Sanofi, Sartorius, Yokogawa Life Science, Corning LifeScience, DeNovix Inc., Elemental Machines, INTEGRA Biosciences, Leica Microsystems, LI-COR Environmental, NanoEntek, Inc., New England Biolabs, Nikon, Promega Corporation , Tecan, ZEISS Microscopy, HitGen Inc., Lundbeck, Stadt Heidelberg, Technologiepark Heidelberg GmbH, Stadt Heidelberg - Amt für Wirtschaftsförderung und Wissenschaft, hip:com and many more.

ATTENTION: cardiometabolic biotech innovators! 🧬💡 Are you revolutionizing the fight against diabetes, obesity, or cardiovascular disease? Novo Nordisk wants to meet YOU! 📅 Mark your calendars: October 11, 2024 🏢 BioLabs Heidelberg Novo Nordisk is offering exclusive in-person meetings with early-stage biotech startups working on: - Type 2 Diabetes breakthroughs - Obesity interventions - Cardiovascular disease solutions - Metabolic disease & rare disorders - Cutting-edge drug discovery tech This is your chance to: ✅ Showcase your groundbreaking research ✅ Get expert feedback ✅ Explore potential collaborations Don't let this opportunity slip away! Apply by September 1, 2024. Ready to change the future of cardiometabolic health? Apply now: https://lnkd.in/gb6vyjVf Thank you Daniel Timmermann and Itai Kela, PhD, MBA for this opportunity. We are happy to welcome you.

Big thanks to Marco Benkisser-Petersen and Holger Dr. Meyer-Waarden from Sartorius for an incredible workshop discovering the #Incucyte world! From mastering experiment scheduling and image analysis to data analysis, we covered it all. We gained a comprehensive overview and are grateful for the invaluable insights, best practice examples, and an extended Q&A session where we could address our specific questions. Can't wait to see our residents leverage these new skills! 🚀 We look forward to our planned 2-day advanced training in September to dive deeper #EmpowringInnovationWorldwide #Research Remi Laliberte, Ann-Kristin Mueller, Heiner Sähr, Ornella Kossi, Nanor Nerkizian, Clément Lapierre

Final Call! European Startups do not miss this opportunity.

🚀 D-2: The European Platinum Ticket – Your Launchpad for Biotech Innovation 🧬 Only two days left to apply for the prestigious European Platinum Ticket program, brought to you by Mission BioCapital, BioLabs, and Eli Lilly and Company. This program offers early-stage life science startups critical funding, lab space at BioLabs, and invaluable mentoring. Don't just take our word for it - hear from Bastian Linder, CSO of Umlaut.bio GmbH, one of our recent winners: “Winning the Platinum Ticket was a significant validation for our team. It propelled us forward, providing the resources to advance from incorporation to intensifying our R&D at BioLabs Heidelberg. Without the Ticket, we might still be confined to a research institute. At BioLabs, we benefit from extensive instruments, a robust network, and numerous partnering opportunities. I highly recommend early-stage startups apply for the European Platinum Ticket – it can be your launchpad. You'll gain crucial feedback and essential support for your innovation and next steps.” Don't miss this opportunity to elevate your startup. Apply now and become part of our dynamic community of biotech pioneers! Apply online until August 2, 2024: https://lnkd.in/eQHMcdaC BioLabs France, BioLabs Heidelberg, Ann-Kristin Mueller, Christophe Tallec, Hélène Sire, Johanna Michielin, Johannes Fruehauf, Jennifer Griffin Let's spread the word on this great chance for European Startups: Life Science Accelerator Baden-Württemberg, German Accelerator, Heidelberg Biotech Simulator, BioRN Life Science Cluster Rhine-Neckar, Nucleate Germany, EMBL, 5-HT Chemistry & Health , EIT Health, HTGF | High-Tech Gründerfonds, CUBEX 41 & CUBEX ONE, H3 Health Hub, Berlin Partner für Wirtschaft und Technologie GmbH, Life Science Nord, Max-Planck-Innovation GmbH, Innovations- und Gründerzentrum (IGZ) Würzburg, Ascenion GmbH, BIO Deutschland e. V., Pieter De Maeght, Philipp Baaske, Garima Bhardwaj, Ph.D., Agnieszka G., Bartosz Kajdas

Today we share another great opportunity for emerging biotech companies: Merck Life Science's EMEA Advance Biotech Grant Program is back for its 10th anniversary, in collaboration with EBD Group! 🧬💡🏆 🎤 Apply now to be one of the five finalists to pitch your ideas in #Stockholm at #BIOEurope this November. Compete for the 2024 grant, which includes over €150,000 in Merck bioprocessing products, services, and consulting. Don't miss out — applications are open until September 9, 2024! 👉 https://lnkd.in/dxVe5ctU Thanks Sylviane BAGHDASSARIAN, Kevin Dillon, Albert Portolés, SANDRINE LOISON for sharing this great program with us. Ann-Kristin Mueller, Ornella Kossi, Clément Lapierre, Heiner Sähr, stephanie fueller, Julia Schaft, Annalisa Zuccotti, Silke Uhrig-Schmidt, Katharina Klotzbach, Katharina Fox, Corinna Herrmann, Bartosz Kajdas, Darius Göttert, Martin Bellof, Volker Erb, Garima Bhardwaj, Ph.D., Birgit Kerber, Friedrich Reinhard, Thomas Hanke, Claus Kremoser, BioLabs France, Johanna Michielin, Felix Güttersberger ... help us spread the word and bring biotech companies on the fast lane with Merck.

A morning of visualization with Thermo Fisher Scientific at BioLabs Heidelberg 🔬 Our residents had the incredible opportunity to join Thermo Fisher Scientific for an in-depth exploration of advanced imaging techniques. Led by Application Scientist Fabian Hahner, the session focused on maximizing the potential of imaging samples. Highlights included: - Rapid multiwell plate scanning - Time-lapse imaging - Z-stacking and autofocus techniques - Live demonstrations We also delved into their powerful Image Analysis Software, featuring: - Advanced segmentation and classification tools - Machine learning algorithms for complex image analysis The best part? Participants brought their own samples, experiencing firsthand the software's capabilities! A big thank you to Christopher Licht for bringing Fabian to our community, and Fabian for this enlightening session! Your expertise and guidance were invaluable. 🙏 Thanks to all who participated! 🙌 We are excited to see how this training will help you thrive. #Microscopy #ImageAnalysis #Empowerment Heiner Sähr, Ornella Kossi, Ann-Kristin Mueller

Are you a #biotech innovator ready to take your startup or academic projects to the next level? Join us for a virtual info session on the VITAL Biotech Accelerator Program and Funding Awards made available through VITAL – A BARDA BAN Hub. Choose your preferred date and time: ➡ Wednesday, August 7 at 3 PM EST (9 PM CET) ➡ Thursday, August 8 at 9 AM EST (3 PM CET) During these sessions, you will: 🔍 Gain insights into the VITAL Biotech Accelerator Program (applications are open until August 23, 2024) 💡 Learn about the non-dilutive funding opportunities ranging from $50K to $200K 📈 Live Q&A This is your chance to learn more about how VITAL can accelerate your growth. Don’t miss this opportunity. Sign up here 👉 https://lnkd.in/eiFEfSdy #HealthTech #GlobalHealth #Vaccines #Therapeutics #Biotech #AcceleratorProgram Biomedical Advanced Research and Development Authority (BARDA) Start2 Group Advise Connect Inspire, LLC BioLabs

Great News, European Biotech Innovators! 🎉 Mission BioCapital, BioLabs and Eli Lilly and Company have extended this year's Platinum program and are offering up to two additional "European Platinum Tickets" which include: 💰 Up to €500K funding  🔬 Premium lab space in Germany/France  🧠 Expert mentoring & business support   Do not miss this chance   Apply by Aug 2, 2024 to accelerate your lifescience startup! Details: https://lnkd.in/eQHMcdaC Spread the word: German Accelerator, THE LÄND, Helmholtz Munich, Nucleate Germany, Silke Uhrig-Schmidt, BioRN Life Science Cluster Rhine-Neckar, EIT Health, KHAN Technology Transfer Fund I, Emblem, HTGF | High-Tech Gründerfonds, Heidelberg Startup Partners e.V., Life Science Accelerator Baden-Württemberg, Katharina Klotzbach, Katharina Fox

BioLabs Heidelberg thrives in the Heidelberg Innovation Park (hip), a dynamic hub for IT, AI, digital, and life sciences. We are proud to be part of this vibrant community (hip:com) where companies and employees connect through collaborative projects, activities, and events. Our recent summer party highlighted the lively spirit of hip. We extend our gratitude to everyone who contributed to making this community-building celebration a success.